{
    "title": "GlaxoSmithKline sees better signs for lung drugs after tough 2014",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2939441/GlaxoSmithKline-sees-better-signs-lung-drugs-tough-2014.html",
    "date": "2015-02-04",
    "keywords": [
        "half",
        "gmt",
        "share",
        "respiratory",
        "medicine",
        "advair",
        "year",
        "novartis",
        "viiv",
        "pressure",
        "percent",
        "glaxosmithkline",
        "lung",
        "email",
        "london",
        "wednesday",
        "market",
        "demand",
        "drug",
        "fourthquarter",
        "drugmakergsk",
        "asset",
        "swap",
        "value",
        "hiv",
        "unit",
        "healthcare",
        "matterchief",
        "executive",
        "andrew",
        "drugmaker",
        "company",
        "performance",
        "yeargsk",
        "cancer",
        "consumer",
        "health",
        "venture",
        "transaction",
        "growth",
        "deal",
        "competition",
        "uptake",
        "breo",
        "measure",
        "average",
        "core",
        "pence",
        "thomson",
        "ben",
        "hirschler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}